Department of Oral and Maxillofacial Surgery, Northwick Park Hospital, London, UK.
Department of Ear, Nose and Throat Surgery, Northwick Park Hospital, London, UK.
Br J Oral Maxillofac Surg. 2024 May;62(4):367-372. doi: 10.1016/j.bjoms.2023.11.022. Epub 2024 Jan 9.
Integra® (Integra LifeSciences) is a well-known dermal regeneration template used in partial and full-thickness wound reconstruction. It can be applied directly on to vascular tissue to create a bed for a skin graft, which is often placed in a second surgery. We present our experience of its novel use in oral and maxillofacial surgery patients, using it directly on bone and cartilage (avascular tissue) without further skin grafting. Patients who required full-thickness excision of lesions down to bone or cartilage and who were treated using Integra® were included. After scalp or ear lesion resection, the collagenous dermal layer of Integra® was placed directly on to bone or cartilage and, along with its outer silicone epidermal layer, secured to the defect with absorbable sutures and a bolster dressing. The wounds were kept dry for 14 days, at which point the dressing and silicone were removed and patients continued regular wound care. Seventeen patients were included, 15 of whom had squamous cell carcinoma. One was lost to follow up. The rest achieved complete healing of the defect. Histology showed epidermis developing on the Integra® surface and at one year, the appearance of normal scarred skin. This novel approach could redefine the uses of Integra®, avoiding the need for free-flap surgery or skin grafting when reconstructing large defects. Further resection of close margins or recurrence is easier after reconstruction using dermal regeneration material than after reconstruction with a local or free flap.
Integra®(英特格拉生命科学公司)是一种众所周知的真皮再生模板,用于部分和全层创面重建。它可以直接应用于血管组织,为皮片移植创造一个床面,通常在第二次手术中进行。我们介绍了其在口腔颌面外科患者中的新用途,即在不进行进一步皮片移植的情况下,将其直接应用于骨和软骨(无血管组织)。纳入了需要全层切除病变至骨或软骨且接受 Integra®治疗的患者。头皮或耳部病变切除后,将 Integra®的胶原真皮层直接放置在骨或软骨上,并与外部硅胶表皮层一起,用可吸收缝线和支撑敷料固定在缺损处。伤口保持干燥 14 天,此时去除敷料和硅胶,患者继续常规伤口护理。纳入了 17 名患者,其中 15 名患有鳞状细胞癌。1 名失访。其余患者均完全愈合。组织学显示表皮在 Integra®表面发育,一年后出现正常瘢痕皮肤。这种新方法可以重新定义 Integra®的用途,避免在重建大面积缺损时需要游离皮瓣手术或皮片移植。使用真皮再生材料重建后,与使用局部皮瓣或游离皮瓣重建后相比,再次切除边缘或复发更容易。